SCHEMBL2937706

SCHEMBL2937706

C[S+]([O-])/C=C/CCN=C=S

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 9/20 0.43
XPO1 O14980 2/20 0.36
NAAA Q02083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL994470 1.00 TRPA1 (0.43) TRPA1XPO1NAAA
SCHEMBL17972498 0.80
SCHEMBL1079374 0.79
SCHEMBL19822550 0.78 TRPA1 (0.38) TRPA1XPO1NAAA
SCHEMBL19822551 0.77 TRPA1 (0.37) TRPA1XPO1
SCHEMBL19822552 0.74 TRPA1 (0.38) TRPA1XPO1
SCHEMBL5334903 0.72
SCHEMBL19822504 0.71 XPO1 (0.52) TRPA1XPO1NAAA
SCHEMBL21048436 0.71 XPO1 (0.52) TRPA1XPO1NAAA
SCHEMBL19822516 0.69 XPO1 (0.40) TRPA1XPO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026086871-A1 ANTI-AGEING COMPOUNDS, USES THEREFOR, METHOD FOR IDENTIFYING, AND COMPOSITIONS CONTAINING Centre for Translational Stem Cell Biology Limited (CN) 2026-04-30 WO claimed
WO-2025215057-A1 NOVEL FORMULATIONS OF ISOTHIOCYANATES, METHODS FOR PREPARATION AND USES THEREOF VIO INVENT PRIVATE COMPANY (GR) 2025-10-16 WO claimed
CN-116487090-B Graphene conductive solution and preparation method and application thereof 深圳市贝加电子材料有限公司 2024-09-06 CN claimed
CN-116875304-B Application of water-soluble sulfonic graphene quantum dot yield increasing agent in promotion of leaf crop yield 江苏大学 2024-07-30 CN claimed
CN-117253996-B Graphene-based lead-carbon battery negative plate and preparation method thereof 湖南京奥新材料科技有限公司 2024-06-07 CN claimed
CN-115534368-B Preparation method of graphene-based migration-preventing layer 湖北航天化学技术研究所 2024-04-05 CN claimed
CN-117253996-A Graphene-based lead-carbon battery negative plate and preparation method thereof 湖南京奥新材料科技有限公司 2023-12-19 CN claimed
CN-117096348-A Positive electrode material composition, positive electrode sheet and battery 三一技术装备有限公司 2023-11-21 CN claimed
CN-116875304-A Application of water-soluble sulfonic graphene quantum dot yield increasing agent in promotion of leaf crop yield 江苏大学 2023-10-13 CN claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-116487090-A Graphene conductive solution and preparation method and application thereof 深圳市贝加电子材料有限公司 2023-07-25 CN claimed
CN-114585729-A Functional neuromodulation assembly 小利兰·斯坦福大学托管委员会 2022-06-03 CN claimed
CN-114556032-A Microbial compositions for preventing or reducing growth of fungal pathogens on plants 博思特生物群落公司 2022-05-27 CN claimed
US-20170246138-A1 METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) 2017-08-31 US claimed
US-9655875-B2 Method of treating or preventing tumors using 1-(alkylsulfinyl)-2-isothiocyanatoalkyl-1-alkene BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) 2017-05-23 US claimed
US-20160220526-A1 METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) 2016-08-04 US claimed
US-20100260737-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2010-10-14 US claimed
EP-2229166-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT Alma Mater Studiorum - Università di Bologna (IT) 2010-09-22 EP claimed
WO-2009083871-A1 COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2009-07-09 WO claimed
WO-1994019948-A1 CHEMOPROTECTIVE ISOTHIOCYANATES CHO CHEON GYU (US) 1994-09-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170246138-A1 METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE BRCA1, VHL, NAT1 TRPA1 730/4885XPO1 4191/4885NAAA 780/4885
US-20160220526-A1 METHOD OF TREATING OR PREVENTING TUMORS USING 1-(ALKYLSULFINYL)-2-ISOTHIOCYANATOALKYL-1-ALKENE BRCA1, VHL, NAT1 TRPA1 730/4885XPO1 4191/4885NAAA 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.